3M New Ventures, the corporate venture organization of 3M, has invested in Zephyr Technology, a developer of real-time physiological monitoring solutions for well-being applications in healthcare, first responder, sports, military, and industrial markets. The series C financing round also included investments by Alsop Louie Partners, Motorola Solutions Venture Capital, and others.
Zephyr is working on ways to monitor human performance through patented smart fabric sensor technology, proprietary algorithms and system design. The biometric sensors for monitoring ECG, heart rate, breathing rate, estimated core temperature, activity and posture and BioSense analysis algorithms provide real-time monitoring of the well-being of people in a wide range of applications.
Stefan Gabriel (President, 3M New Ventures): Measuring the performance and condition of people, workers, and patients is becoming increasingly important from a safety and performance standpoint.
3M New Ventures, headquartered in Munich, Germany, invests in companies and disruptive technologies with strategic relevance for 3M. The focus areas encompass energy, sustainability and water; health; electronics, IT and media; architecture, light and living; mobility and transportation; and safety and security.